Kura Oncology Inc. (KURA)

KURA trades at $9.57, 27.6% above the near-term max pain of $7.5 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($5-$7.5), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for KURA shows an upward trend from 5 to 7.5, suggesting bullish positioning in longer-dated options. The 39% spread signals divergent expectations across timeframes. Most levels below 9.57 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.